{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:58:14Z","timestamp":1773853094037,"version":"3.50.1"},"reference-count":56,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/21645515.2026.2644731","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:28:39Z","timestamp":1773829719000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine"],"prefix":"10.1080","volume":"22","author":[{"given":"Vinay","family":"Gavade","sequence":"first","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandrashekhar","family":"Kamat","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Avalaskar","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Haridasyam","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somnath","family":"Sargar","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash","family":"Chavan","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaibhav","family":"Jadhav","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Kadam","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balu","family":"Borude","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamraju D.","family":"Sarma","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha","family":"Mallya","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev M.","family":"Dhere","sequence":"additional","affiliation":[{"name":"Serum Institute of India Pvt. Ltd","place":["Pune, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30685-6"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.047159-0"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00115-14"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0042-96862004000500008"},{"key":"e_1_3_5_6_1","volume-title":"Typhoid Vi polysaccharide vaccine [prescribing information]","author":"Typhim Vi\u00ae","year":"2005","unstructured":"Typhim Vi\u00ae. Typhoid Vi polysaccharide vaccine [prescribing information]. Lyon, France: Sanofi Pasteur SA; 2005."},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32149-9"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.045"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005857117"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1117715"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/cidciv295"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.2495"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy884"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00532-10"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1145"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.022"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab393"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010091"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.25.12.2266-2269.1987"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2020.05.002"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.050"},{"issue":"5","key":"e_1_3_5_22_1","first-page":"473","article-title":"Preparation and immunogenicity-evaluation of typhoid O-specific polysaccharides bio-conjugate vaccines","volume":"37","author":"Peng YH","year":"2015","unstructured":"Peng YH, Pan C, Sun P, Feng EL, Wu J, Zhu L, Peng QZ, Wang HL. Preparation and immunogenicity-evaluation of typhoid O-specific polysaccharides bio-conjugate vaccines. Yi Chuan. 2015;37(5):473\u2013479.","journal-title":"Yi Chuan"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-017-0037-1"},{"issue":"6","key":"e_1_3_5_24_1","first-page":"533","article-title":"Stable expression and immunogenicity in a attenuated Salmonella Typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli","volume":"39","author":"Teng J","year":"1999","unstructured":"Teng J, Rui X, Zhang Y, Zhang Z, Su G. Stable expression and immunogenicity in a attenuated Salmonella Typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli. Wei Sheng Wu Xue Bao. 1999;39(6):533\u2013538.","journal-title":"Wei Sheng Wu Xue Bao"},{"key":"e_1_3_5_25_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use ICH harmonised guideline validation of analytical procedures Q2(R2). 2023 Nov 1."},{"key":"e_1_3_5_26_1","unstructured":"Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial. llse De Coster MDa \u2219 Mohammad AbdelGhany MDb mohammad.a.abdelghany@gsk.com \u2219 Eleanna Sarakinou MScb \u2219 Chiara Fineschi MScb \u2219 Elisa Marchetti PhDb \u2219 Rita La Gaetana MScb \u2219 Simona Nigro MScb \u2219 Martina Carducci PhDb \u2219 Luisa Massai Mscb \u2219 Valentino Conti MScb \u2219 Omar Rossi PhDb \u2219 Giulia Luna Cilio MScc \u2219 Alimamy Serry-Bangura MDc \u2219 Pietro Tessitore MScc \u2219 Prof Pierre Van Damme MDa \u2219 Kanchanamala Withanage MDa \u2219 Francesca Micoli PhDb \u2219 Francesco Berlanda Scorza PhDb \u2219 Simona Rondini PhDb \u2219 Usman N Nakakana MDb d \u2219 Ashwani Kumar Arora MD."},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix042"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2015.07.004"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.09.074"},{"issue":"5","key":"e_1_3_5_30_1","first-page":"SC01","article-title":"A study on longevity of immune response after vaccination with Salmonella Typhi Vi conjugate vaccine (Pedatyph\u2122) in children","volume":"9","author":"Chinnasami B","year":"2015","unstructured":"Chinnasami B, Sadasivam K, Vivekanandhan A, Arunachalam P, Pasupathy S. A study on longevity of immune response after vaccination with Salmonella Typhi Vi conjugate vaccine (Pedatyph\u2122) in children. J Clin Diagn Res. 2015;9(5):SC01\u2013SC03.","journal-title":"J Clin Diagn Res"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02582"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1905047"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.02.050"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189100"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2016.05.013"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.3390\/biotech10030019"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01916"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2018.06.025"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.12.2.287-295.2005"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00106-16"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00249-6"},{"key":"e_1_3_5_42_1","unstructured":"Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG. Sjoerd Rijpkemaa * Jason Hockleyb Alastair Logana Peter Rigsbyb Eleanor Atkinsonb Celina Jinc David Goldblattd Haoyu Liange Novilia S. Bachtiarf Jae Seung Yangg Akshay Goelh Venkatesan Ramasamyi Marcela F. Pasettij Andrew J. Pollardc the anti-Vi IgG working group."},{"key":"e_1_3_5_43_1","first-page":"72","volume-title":"Who expert committee on biological standardization: sixty-eighth report","year":"2018","unstructured":"First WHO international standard for anti-typhoid capsular Vi polysaccharide immunoglobulin G (human). In: Who expert committee on biological standardization: sixty-eighth report. Geneva: World Health Organization; 2018. WHO Technical Report Series, No. 1011, section 8.1.4. p. 72\u201373."},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2018.11.004"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2018.09.001"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.02.006"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.10.5.780-786.2003"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071394"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00131-10"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201116"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.2310\/7060.2005.12604"},{"key":"e_1_3_5_52_1","unstructured":"Watkins LKF Shih DC Dorough L. Typhoid & paratyphoid fever - chapter 4 - 2020 yellow book. Travelers\u2019 Health. CDC [Internet]. CDC Yellow Book: Health Information for International Travel; 2026 [accessed 2022 Feb 4]. https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2020\/travel-related-infectious-diseases\/typhoid-and-paratyphoid-fever."},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004926"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008783"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-007481"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"e_1_3_5_57_1","volume-title":"Who expert committee on biological standardization: sixty-third report","year":"2021","unstructured":"Recommendations to assure the quality, safety and efficacy of typhoid conjugate. In: Who expert committee on biological standardization: sixty-third report. Geneva: World Health Organization; 2021. Replacement to Annex 3 (WHO Technical Report Series, No. 987)."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2026.2644731","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:28:41Z","timestamp":1773829721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2026.2644731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/21645515.2026.2644731"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2026.2644731","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2644731"}}